The Director of Policy & Government Affairs – Science and FDA Policy will lead Regeneron’s science and FDA policy portfolio, developing, shaping and influencing government and multinational organization policy related to the scientific research and development of biopharmaceutical medicine and cell and gene therapy across the product lifecycle. Relevant issues include but are not limited to product approval standards and pathways, scientific ethics and integrity, clinical trial activity, evidence development, manufacturing and CMC criteria, and biosimilars. Although US-focused, the position may also support the ex-US Public Policy & Government Affairs lead on key science and biotechnology medicine policy around the world as needed.

**A typical day may include the following:**

+ Engage with internal subject matter experts and leaders to understand Regeneron’s business and corporate interests, recognize policy risks and opportunities, and determine short and long-term p...